Advertisement
Advertisement

SMTI

SMTI logo

Sanara MedTech Inc. Common Stock

18.40
USD
Sponsored
-0.68
-3.56%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

18.65

+0.25
+1.36%

Sanara MedTech Inc. Common Stock Profile

About

Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas.

Info & Links

CEO

Seth D. Yon

Headquarters

1200 Summit Avenue, Suite 414
Fort Worth, TX 76102, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.sanaramedtech.com

Auditor

Weaver and Tidwell, L.L.P

Share holders

290

Employees

108

Sanara MedTech Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

170.92M

Enterprise Value

200.31M

Enterprise Value/EBITDA(ttm)

17.37

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.51

Price to Book(mrq)

25.48

Price to Cash(ytd)

28.54

Profitability

Gross Margin(ttm)

92.69%

Operating Margin(ttm)

-4.23%

Profit Margin(ttm)

-36.05%

Return on Equity(ttm)

-20.73%

Return on Invested Capital(ttm)

3.01%

Return on Assets(ttm)

-5.14%

Income Statement

Revenue(ttm)

103.12M

Revenue Per Share(ttm)

11.25

Gross Profit(ttm)

95.60M

EBITDA(ttm)3

11.53M

Net Income Available to Common(ttm)

-37.56M

Diluted EPS(ttm)

-4.23

Share Statistics

Beta (5Y Monthly)

1.10

52-Week Change

-43.21%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.17M

Dividend Yield

0.00%

Float4

5.26M

% Held by Insiders

42.60%

% Held by Institutions

8.10%

Balance Sheet

Total Cash(mrq)

16.58M

Total Cash Per Share(mrq)

1.81

Total Debt(mrq)

45.97M

Total Debt/Equity(mrq)

775.26%

Current Ratio(mrq)

1.80%

Quick Ratio(mrq)

1.59%

Book Value Per Share(mrq)

0.66

Cash Flow

Operating Cash Flow Per Share(ytd)

0.79

Free Cash Flow(ytd)

2.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement